AtriCure (ATRC) Misses Q4 EPS by 1c

AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $49.5 million versus the consensus estimate of $59.5 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79